富蘭克林坦伯頓全球投資系列-生技領航基金美元F(acc)股
14.92美元0.5(3.24%)
2021/02/25更新
績效 / 1月0.78%
3月11.9%
1年31.79%
晨星評等-
- 1.現金4.21%
- 2.股票11.35%
- 3.債券0.00%
- 4.其他84.44%
- 1.美國83.01%
- 2.英國4.63%
- 3.新興亞洲2.16%
- 4.加拿大2.07%
- 5.歐洲不包含歐元區1.40%
- 1.Gilead Sciences Inc6.40%
- 2.Vertex Pharmaceuticals Inc5.44%
- 3.Regeneron Pharmaceuticals Inc5.03%
- 4.Amgen Inc4.96%
- 5.Illumina Inc4.54%
- 6.GW Pharmaceuticals PLC ADR4.53%
- 7.Iovance Biotherapeutics Inc3.94%
- 8.Novavax Inc3.46%
- 9.Federal Home Loan Banks 0%3.17%
- 10.PTC Therapeutics Inc2.86%
- 1.現金4.21%
- 2.股票11.35%
- 3.債券0.00%
- 4.其他84.44%
- 1.美國83.01%
- 2.英國4.63%
- 3.新興亞洲2.16%
- 4.加拿大2.07%
- 5.歐洲不包含歐元區1.40%
- 1.Gilead Sciences Inc6.40%
- 2.Vertex Pharmaceuticals Inc5.44%
- 3.Regeneron Pharmaceuticals Inc5.03%
- 4.Amgen Inc4.96%
- 5.Illumina Inc4.54%
- 6.GW Pharmaceuticals PLC ADR4.53%
- 7.Iovance Biotherapeutics Inc3.94%
- 8.Novavax Inc3.46%
- 9.Federal Home Loan Banks 0%3.17%
- 10.PTC Therapeutics Inc2.86%